|
Tuesday April 8, 2014 |
| Session Chair |
Dr Pascal GEORGE (SCT & INDEPENDENT SCIENTIFIC EXPERT & ADVISER, Longvilliers, France) |
09:30 | Introduction |
|
09:45 | Mechanism Based Delivery Systems (Tentative title) |
Dr John F. GILMER (TRINITY COLLEGE DUBLIN, dublin, Ireland) |
10:30 | Coffee Break |
|
| Session Chair |
Prof. Bernard LEBLEU (INDEPENDENT SCIENTIFIC EXPERT, SFNANO, Montpellier, France) |
11:00 | On the Cutting Edge: Proteolytically-Induced Drug Delivery in Imaging and Photodynamic Therapy |
Prof. Norbert LANGE (UNIVERSITY OF GENEVA, Geneva, Switzerland) |
| Session Chair |
Dr Frédéric SCHMIDT (INSTITUT CURIE, Paris, France) |
11:45 | Designing Polymer-Based Combination Therapy for the Treatment of Cancer |
Dr Maria VICENT (RESEARCH CENTRE PRÍNCIPE FELIPE, Valencia, Spain) |
12:30 | Lunch |
|
| Session Chair |
Prof. Didier BETBEDER (UNIVERSITY LILLE 2, Lille, France) |
14:00 | Homogeneous Conjugated Antibody with Single Point Mutation Using Bacterial Transglutaminase |
Dr Florence LHOSPICE (INNATE PHARMA, Marseille, France) |
| Session Chair |
Prof. Janos SAPI (SCT & UNIVERSITY OF REIMS-CHAMPAGNE-ARDENNE, Reims, France) |
14:45 | PK/PD Challenges for Antibody Drug Conjugates Development |
Dr Antoine DESLANDES (SANOFI R&D, Paris, France) |
15:30 | Coffee Break |
|
| Session Chair |
Dr Nathalie MIGNET (CNRS UMR8151, PRESIDENT SFNANO, Paris, France) |
16:00 | Chemical and Physiological Considerations in the Design of Nanosized Drug Carriers for Cancer Chemotherapy |
Prof. Jean-Christophe LEROUX (ETH ZÜRICH, Zürich, Switzerland) |
16:45 | Final Conclusions |
|
17:00 | Meeting Closure |
|
|